Dr. Reddy's Laboratories
128 hedge funds and large institutions have $1.07B invested in Dr. Reddy's Laboratories in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 19 closing their positions.
6% more capital invested
Capital invested by funds: $1B → $1.07B (+$61M)
0.79% more ownership
Funds ownership: 75.46% → 76.25% (+0.79%)
9% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 46
4% less funds holding
Funds holding: 134 → 128 (-6)
12% less call options, than puts
Call options by funds: $548K | Put options by funds: $623K
32% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$20M |
| 2 |
AI
Axiom Investors
Greenwich,
Connecticut
|
-$11.1M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.12M |
| 5 |
BlackRock
New York
|
-$2.83M |
RDY Hedge Fund Activity: Q2 2017 in Review
128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2017, worth a combined $1.07B — up 6.1% from $1B a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of RDY and 13 opened new positions — a net loss of 6 holders — while 46 trimmed existing stakes and 42 added.
The largest buyer was Royal Bank of Canada, adding an estimated $36.3M. The largest seller was AQR Capital Management, cutting an estimated $20M.
- 128 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2017, down from 134 in Q1 2017.
- Funds reported $1.07B of Dr. Reddy's Laboratories stock for Q2 2017, up 6.1% quarter-over-quarter.
- 13 funds opened new Dr. Reddy's Laboratories positions in Q2 2017 and 19 closed out, a net change of -6 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2017 was Royal Bank of Canada, an estimated $36.3M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2017 was AQR Capital Management, an estimated $20M sold.
Based on aggregated 13F filings for Q2 2017.